Pharyngitis
📧 Sign up to get email alerts when something new happens for Pharyngitis.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2019-06-19EMA Withdrawn: Ketek (telithromycin) — Aventis Pharma S.A.
Telithromycin (Ketek) has been withdrawn from the European market by Aventis Pharma S.A. after regulatory assessment.
-
CLINICAL_TRIALS withdrawal · 2018-03-07Clinical Trial Update: A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions [Phase 1]
A Phase 1 bioequivalence study comparing SKF101804 cefixime to a cefixime reference formulation in healthy adults under fasting conditions h…
-
CLINICAL_TRIALS withdrawal · 2011-08-30Clinical Trial Update: Comparison Between Two Methods of Throat Swabbing [NA]
The clinical trial comparing two throat-swabbing methods for pharyngitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2009-04-03Clinical Trial Update: TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults [Phase 3]
The TELI TAD Phase 3 trial evaluating telithromycin for tonsillitis and pharyngitis in adolescents and adults has been terminated.
-
EMA withdrawal · 2008-02-14EMA Withdrawn: Levviax (telithromycin) — Aventis Pharma S.A.
Telithromycin (Levviax) has been withdrawn from the market by Aventis Pharma S.A. for community-acquired infections including pharyngitis, b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.